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ABSTRACT
Objectives: Test the hypothesis of no difference in implant treatment outcomes after maxillary sinus floor augmentation with 
or without barrier membrane coverage of the lateral window. 
Material and Methods: A MEDLINE (PubMed), Embase and Cochrane library search in combination with a hand-search of 
relevant journals was conducted. Human studies published in English until the 5th of July, 2019 were included. Randomised 
controlled trials and controlled trials with an observation period of minimum six months were included. Primary outcomes 
included survival of suprastructures and implants. Secondary outcomes included implant stability quotient, peri-implant 
marginal bone loss, bone regeneration, patient-reported outcome measures, biologic and mechanical complications.
Results: The electronic search and hand-searching resulted in 1068 entries. Six randomised controlled trials characterised by 
low to high risk of bias and one controlled trial with high risk of bias fulfilled the inclusion criteria. High implant survival 
rate was reported with both treatment modalities. Meta-analyses disclosed a mean difference of newly formed bone of 6.4% 
(confidence interval = 0 to 12.9) and non-mineralised tissue of -1.1% (confidence interval = -2.7 to 0.5), indicating more 
newly formed bone and diminished non-mineralised with barrier membrane coverage.
Conclusions: There seem to be no statistically significant differences in implant treatment outcomes after maxillary sinus 
floor augmentation with or without barrier membrane coverage of the lateral window. However, barrier membrane coverage 
increases percentage of newly formed bone and diminishes proliferation of non-mineralised tissue. Thus, barrier membrane 
coverage seems to be beneficial and also preventing displacement of the grafting material.
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INTRODUCTION
Maxillary sinus floor augmentation (MSFA) 
applying the lateral window technique is the most 
commonly used surgical procedure to increase the 
alveolar bone height of the posterior maxilla before 
or in conjunction with implant placement, and the 
treatment outcome involving different types of 
grafting materials have been documented in several 
systematic reviews and meta-analyses [1-8]. Barrier 
membrane coverage of the lateral window has been 
recommended to prevent soft tissue interference and 
improve bone regeneration as well as stabilisation 
of the grafting material [9-11]. However, barrier 
membrane coverage of the lateral window is 
associated with lower vascular supply to the applied 
grafting material, increased risk of infection 
and additional cost. Moreover, non-absorbable 
membranes have to be removed and occasionally 
lead to complications such as wound dehiscence 
[11]. Systematic reviews have demonstrated high 
implant survival rate after MSFA with barrier 
membrane coverage of the lateral window [12-15]. 
In addition, increased percentage of vital bone after 
graft maturation have also been reported with barrier 
membrane coverage compared with the use of no 
barrier membrane coverage [16,17]. However, further 
systematic reviews and meta-analyses have concluded 
that the implant survival rate and amount of vital bone 
formation were not influenced by barrier membrane 
coverage [18-21]. Consequently, the effectiveness 
of barrier membrane coverage of the lateral window 
in conjunction with MSFA remains disputable. The 
rationale for this systematic review is therefore to 
investigate whether barrier membrane coverage 
of the lateral window in conjunction with MSFA 
is necessary since the use of a barrier membrane 
increases the cost of the treatment and involves a risk 
of contamination and disease transmission as well as 
they can be refused by patients for religious reasons 
or because they are in contrast with chosen lifestyle. 
The objective of the present systematic review and 
meta-analysis is therefore to test the hypothesis of no 
difference in implant treatment outcomes after MSFA 
with or without barrier membrane coverage of the 
lateral window. 
MATERIAL AND METHODS
Protocol and registration
The present systematic review was conducted in 
accordance with the Preferred Reporting Items for 
Systematic reviews and Meta-Analyses (PRISMA) 
statement for reporting systematic reviews [22]. 
The PRISMA checklist is outlined in Appendix 
1. The methods of analysis and inclusion criteria 
were specified in advance and documented in a 
protocol. The review was registered in PROSPERO, 
an international prospective register of systematic 
reviews. Registration number: CRD42019139519.
The protocol can be accessed at:
https://www.crd.york.ac.uk/prospero/display_record.
php?ID=CRD42019139519.
Focus question
The focus question was developed according to the 
Patient, Intervention, Comparison and Outcome 
(PICO) framework as described in Table 1. 
Focus question: Are there any differences in implant 
treatment outcomes after MSFA with or without 
barrier membrane coverage of the lateral window?
Types of studies and publications
The present systematic review included randomised 
controlled trials and controlled trials on humans. 
Population
The included studies of the present systematic review 
involved healthy adult partially or totally edentulous 
Table 1. PICOS guidelines
Patient and population (P) Healthy adult patients with atrophy of the posterior part of the maxilla receiving maxillary sinus floor augmentation applying the lateral window technique.
Intervention (I) Barrier membrane coverage of the lateral window.
Comparator or control group (C) No barrier membrane coverage of the lateral window.
Outcomes (O)
Primary outcomes included survival of suprastructures and implants. Secondary outcomes included 
implant stability quotient, peri-implant marginal bone loss, bone regeneration, patient-reported 
outcome measures, biologic and mechanical complications.
Study design (S) Randomised controlled trials and controlled trials with an observation period of minimum six months.
Focused question Are there any differences in implant treatment outcomes after maxillary sinus floor augmentation with or without barrier membrane coverage of the lateral window?
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patients with atrophy of the posterior part of the 
maxilla receiving MSFA applying the lateral 
window technique with or without barrier membrane 
coverage.
Types of outcome measures
The primary outcome measures are the most 
important measures for evaluating of the final implant 
treatment outcomes. Secondary, outcome measures 
were also included in the present systematic review as 
surrogate measures. 
The primary outcome measures included:
• Survival of suprastructures. Loss of suprastructure 
was defined as a total loss because of a 
mechanical and/or biological complication.
• Survival of implants. Loss of implants was 
defined as mobility of previously clinically 
osseointegrated implants and removal of non-
mobile implants due to progressive peri-implant 
marginal bone loss and infection.
Moreover, the following secondary outcome measures 
were assessed:
• Implant stability quotient. Estimated by resonance 
frequency analysis. 
• Peri-implant marginal bone loss. Evaluated by 
radiographic measurements.
• Bone regeneration. Percentage of newly formed 
bone, non-mineralized tissue and residual 
graft material as evaluated by radiographic or 
histologic measurements.
• Patient-reported outcome measures.
• Biologic and mechanical complications.
Information sources
The search strategy incorporated examinations of 
electronic databases, supplemented by a thorough 
hand-search page by page of relevant journals 
including “British Journal of Oral and Maxillofacial 
Surgery”, “Clinical Implant Dentistry and Related 
Research”, “Clinical Oral Implants Research”, 
“European Journal of Oral Implantology”, “Implant 
Dentistry”, “International Journal of Oral and 
Maxillofacial Implants”, “International Journal of 
Oral and Maxillofacial Surgery”, “International 
Journal of Periodontics and Restorative Dentistry”, 
“International Journal of Prosthodontics”, “Journal 
of Clinical Periodontology”, “Journal of Dental 
Research”, “Journal of Oral Implantology”, “Journal 
of Oral & Maxillofacial Research”, “Journal of 
Periodontology”, “Journal of Prosthetic Dentistry”, 
“Journal of Craniofacial Surgery”, “Journal of 
Cranio-Maxillo-Facial Surgery”, “Journal of Oral 
and Maxillofacial Surgery”, “Periodontology 2000”, 
“Oral and Maxillofacial Surgery” and “Oral Surgery 
Oral Medicine Oral Pathology Oral Radiology”. The 
manual search also included the bibliographies of 
all articles selected for full-text screening as well as 
previously published reviews relevant for the present 
systematic review. 
Search
A MEDLINE (PubMed), Embase, and Cochrane 
Library search was conducted. Human studies 
published in English until the 5th of July, 2019 
were included. The search strategy was performed 
in collaboration with a librarian and utilized a 
combination of Medical subject heading (MeSH) 
and free text terms. The search strategy is outlined in 
Appendices 2, 3 and 4.
Selection of studies
The titles of the identified reports were initially 
screened. The abstract was assessed when the 
title indicated that the study was relevant. Full-
text analysis was obtained for those with apparent 
relevance or when the abstract was unavailable. The 
references of the identified papers were cross-checked 
for unidentified articles. 
Study eligibility
The inclusion criteria were developed using the 
PICOS guidelines (Table 1).
Inclusion criteria
The review exclusively focused on studies with 
an observation period of minimum six months 
after MSFA. In addition, at least five patients 
should be included in the study and the number 
of sinus augmentation procedures must be clearly 
specified. 
Exclusion criteria
Studies with implant placement in medically 
compromised patients as well as studies with 
insufficient description of the performed numbers of 
surgical procedures or length of observation period 
were excluded. Moreover, letters, editorials, PhD 
theses, letters to the editor, case reports, abstracts, 
technical reports, conference proceedings, animal or 
in vitro studies and literature review papers were also 
excluded.
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Data extraction
Data were extracted according to a data-collection 
form ensuring systematic recording of the outcome 
measures. In addition, relevant characteristics of 
the study were recorded. The corresponding author 
was contacted by e-mail in the absence of important 
information or uncertainties.
Data items
The following items were collected from the included 
articles and arranged in the following fields: author, 
year of publication, study design, number of patients, 
MSFA procedures, residual alveolar bone height, 
type of grafting material, membrane, number of 
implants, prosthetic solution, length of observation 
period, survival of suprastructure and implants, 
implant stability quotient, peri-implant marginal bone 
loss, bone regeneration, biologic and mechanical 
complications.  
Assessment of methodological quality 
The quality assessment of the included studies was 
undertaken as part of the data extraction process. A 
methodological quality rating system was used and 
the classification of the risk of bias potential for each 
study was based on the following five criteria [1,2]: 
1. Random selection in the population (yes/no).
2. Definition of inclusion, exclusion criteria (yes/no).
3. Report of losses to follow-up (yes/no).
4. Validated measurements (yes/no).
5. Statistical analysis (yes/no).
The studies were grouped according to:
1. Low risk of bias (plausible bias unlikely to 
seriously alter the results) if all above-described 
quality criteria were met.
2. Moderate risk of bias (plausible bias that weakens 
confidence in the results) when one of these 
criteria were not included.
3. High risk of bias (plausible bias that seriously 
weakens confidence in the results) when two or 
more criteria were missing.
Statistical analysis
Meta-analyses were to be conducted only if there 
were studies of similar comparison, reporting identical 
outcome measures. However, the included studies of 
the meta-analysis revealed variations in study design, 
i.e. size of the lateral window, residual height of the 
alveolar process, dimension of the sinus cavity, use of 
nonresorbable and resorbable membranes, dissimilar 
grafting material, bone cores for histomorphometric 
analysis were retrieved at different locations, types of 
outcome measures, length of the graft healing period 
and observation period. Therefore, a well-defined 
meta-analysis was not applicable. However, the 
percentage of newly formed bone and non-mineralised 
tissue across comparable studies were analysed in 
a meta-analysis. Forest plots were drawn to show a 
summary of the histomorphometric characteristics 
and expressed as the mean difference (MD) between 
MSFA with barrier membrane coverage of the lateral 
window and without barrier membrane coverage 
with the mean expressed in percentage. The 95% 
confidence interval (CI) was also calculated. 
Parametric data were expressed as mean and standard 
deviation (M [SD]). Statistical significance level was 
defined at P = 0.05. 
Assessment of heterogeneity
The significance of any discrepancies in the estimates 
of the treatment effects of the different studies was 
assessed by means of Cochran’s test for heterogeneity 
and the I2 statistic, which describes the percentage 
of total variation across studies that is due to 
heterogeneity rather than chance. Heterogeneity was 
considered statistically significant if P < 0.1. A rough 
guide to the interpretation of I2 given in the Cochrane 
Handbook for Systematic Reviews of Interventions is 
as follows: (1) at 0 - 40% the heterogeneity might not 
be important, (2) 30 - 60% may represent moderate 
heterogeneity, (3) 50 - 90% may represent substantial 
heterogeneity, and (4) 75 - 100% may represent 
considerable heterogeneity [23].
RESULTS
Study selection
Article review and data extraction were performed 
according to the PRISMA flow diagram (Figure 1). 
The electronic search resulted in 1067 entries. One 
article was identified through hand-searching [16]. 
Of these 1068 articles, 427 were excluded because 
they had been retrieved in more than one search. 
A total of 31 abstracts were reviewed and full-text 
analysis included 12 articles. Finally, seven studies 
were included in the present systematic review [16,17, 
24-28]. 
Exclusion of studies
The reasons for excluding studies after full-text 
assessment were as follows: retrospective study 
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without a control group [29], MSFA with two-window 
technique [30]. Moreover, three studies could not be 
excluded before meticulous reading [31-33].
Study characteristics 
The included studies of the present systematic 
review consisted of six randomised controlled trials 
[16,17,24,26-28] and one controlled clinical trial 
[25]. A split-mouth study design was used in three 
randomized controlled trials [17,26,28]. Partially and 
totally edentulous patients with horizontal deficiencies 
of the maxillary alveolar ridge were enrolled in the 
included studies. No significant difference in patient 
demographics were reported in two studies [27,28]. 
Inclusion and exclusion criteria were specified in 
all the included studies [16,17,24-28]. Patients with 
controlled diabetes were not excluded in three studies 
[16,17,25] and smoking habits were not excluded in 
six studies [16,17,24,25,27,28]. The residual bone 
height was described in three studies [24,27,28]. 
Power calculation was performed in one study [28]. 
CONSORT guidelines were followed in one study 
[27]. Randomisation was conducted using a computer 
generated random allocation process [27,28] or no 
information was provided about the randomisation 
procedure [16,17,24,26]. The surgical procedure was 
performed by the same surgeon [28], two surgeons 
[27] or no information was provided about the 
number of surgeons involved in the study [16,17,24-
26]. Dimension of the lateral window was measured 
in one study [27]. Various grafting materials were 
used involving OsteoGraf/N® (CeraMed, Lakewood, 
Colorado, USA) alone or in combination with varying 
percentages of autogenous bone or demineralized 
freeze-dried bone allograft [16], Bio-Oss® (Geistlich 
Pharma AG, Wolhusen, Switzerland) [24,28], Bio-
Oss® (Osteohealth Co., Shirley, NY, US) alone or in 
combination with a maximum of 20% autogenous 
bone graft from the maxillary tuberosity or ascending 
mandibular ramus [25], mixture of 50% particulated 
autogenous bone graft from the lateral bone wall 
and 50% collagenated corticocancellous porcine 
bone (MP3®; Osteobiol-Tecnoss, Coazze, Italy) [27], 
Bio-Oss® (Osteohealth, Newport Beach, California, 
USA) [26] or various grafting materials [17]. 
Different barrier membranes were used to cover the 
lateral window involving non-resorbable expanded 
polytetrafluoroethylene (e-PTFE) membrane (Goretex 
Augmentation Material, 3i, W. L. Gore) [16,17,25] or 
resorbable collagen Bio-Gide® membrane (Geistlich 
Pharma AG, Wolhusen, Switzerland) [24,28], Bio-
Gide® membrane (Osteohealth Co., Shirley, New 
York, USA) [25] (Osteohealth, Newport Beach, 
Figure 1. PRISMA flow diagram demonstrating the results of the systematic literature search.
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California, USA) [26], and Evolution (Osteobiol-
Tecnoss, Torino, Italy) [27]. Fixation of the covering 
barrier membrane was conducted in six studies 
[16,17,24-26,28]. Frios® tacks (Friadent GmbH, 
Mannheim, Germany) were used in one study [24], 
while no information was provided in five studies 
about the used tacks [16,17,25,26,28]. MSFA with 
delayed implant placement were performed in three 
studies after 6 to 10 months of graft healing [25-
27]. MSFA involving both immediate and delayed 
implant placement was performed in four studies 
[16,17,24,28]. Different implant systems were used 
including screw-type machined-surface implants 
(Brånemark System®; Nobel Biocare, Gothenburg, 
Sweden) [24] and Osseotite® (Biomet 3i Inc., 
Palmbeach, Florida, USA) [28]. The used implant 
system was not specified in five studies [16,17,25-
27]. Histomorphometric parameters were assessed 
in six studies [16,25-28], after six months [27,28], 6 
to 9 months [16], 6 to 10 months [25], eight months 
[26] or 7 to 13 months [17], respectively. The bone 
cores were retrieved with trephine drill through the 
previous lateral window [16,17,25-27] or at implant 
placement sites [28]. None of the included studies 
provided information about training or calibration of 
the examiners assessing the clinical and radiographic 
outcome. Information about blinding assessment 
was described in one study [28]. Numbers of drop 
outs were described in two studies [26,27]. Survival 
of suprastructures, implant stability quotient, peri-
implant marginal bone loss and patient-reported 
outcome measures was not reported in any of the 
included studies. Thus, these outcome measures are 
not described in the following section or outlined in 
Table 2.
Outcome measures
The result of each outcome measure is presented first 
and then a short summary is finally provided. The 
results of the outcome measures are outlined in Table 
2.
Survival of implants 
Survival of implants with a non-resorbable covering 
barrier membrane (e-PTFE) was 99% compared with 
96% without a membrane [16]. No statistical analysis 
was performed [16].
Survival of implants with a non-resorbable covering 
barrier membrane (e-PTFE) was 100% compared with 
93% without a membrane, after 0 to 5 years [17]. No 
statistical analysis was performed [17].
Survival of implants with a resorbable covering 
collagen barrier membrane (Bio-Gide®) was 93% 
compared with 78% without a membrane, after 12 - 
40 months [24]. No statistical analysis was performed. 
There was no difference in implant failure rate 
between MSFA with immediate or delayed implant 
placement when membrane coverage of the lateral 
window was performed. While, an increased implant 
failure rate was reported after MSFA and immediate 
implant placement without barrier membrane 
coverage of the lateral window [24]. 
Survival of implants after MSFA with a resorbable 
collagen covering barrier membrane (Bio-Gide®) or a 
non-resorbable covering barrier membrane (e-PTFE) 
was 98% compared with 100% without a membrane, 
after one year of functional implant loading [25]. No 
statistical analysis was performed [25]. 
Survival of implants after MSFA with a resorbable 
covering collagen barrier membrane (Bio-Gide®) was 
96% compared with 94% without a membrane, after 
one year of functional implant loading [28]. There 
was no statistically significant difference in implant 
survival rate between the two treatment modalities 
(P = 0.08). However, immediate implant placement 
revealed a statistically significant higher implant 
failure rate compared with delayed implant placement 
(P = 0.04) [28]. 
Summary
MSFA with or without barrier membrane coverage 
of the lateral window seems not to significantly 
influence the implant survival rate. However, a 
higher percentage of implant failures were reported 
after MSFA without barrier membrane coverage and 
immediate implant placement.  
Bone regeneration 
Percentage of newly formed bone after MSFA with a 
non-resorbable covering barrier membrane (e-PTFE) 
varied between 17 - 33% compared with 9 - 19% 
without a membrane, after 6 to 9 months [16]. No 
statistical analysis was performed [16].
Percentage of newly formed bone after MSFA with a 
non-resorbable covering barrier membrane (e-PTFE) 
was 26 (15)% compared with 11 (8)% without a 
membrane, after 7 to 13 months [17]. No statistical 
analysis was performed [17]. 
Percentage of newly formed bone, non-mineralised 
tissue and residual graft material after MSFA with a 
non-resorbable covering barrier membrane (e-PTFE) 
was 17%, 51% and 32%, after 6 to 10 months, 
respectively [25]. Resorbable covering collagen barrier 
membrane (Bio-Gide®) revealed 18%, 56% and 26%. 
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Table 2. Maxillary sinus floor augmentation with or without barrier membrane coverage of the lateral window
Study Year ofpublication
Study
design NOP
Materials and methods Outcome measures
MSFA RBH(mm)
Type of grafting 
material Membrane
Number of 
implants
Prosthetic
solution
LOP 
(month)
Survival of
implants 
(%)
Bone regeneration
(%)
Biologic and 
mechanical
complicationsNFB NMT RG
Froum et al. [16] 1998 RCT 113 113 NR
Combination of 
different grafting 
materials
e-PTFE: 79 133
NR 6 - 9
99 17 - 33
NR NR
No membrane coverage: 34 82 96 9 - 19
Tarnow et al. [17] 2000
RCT, 
split-
mouth
12 12 NR
Combination of 
different grafting 
materials
e-PTFE: 12 28
NR 7 - 13
100 26(SD 15)
NR NR
No membrane coverage: 12 27 93 12(SD 8)
Tawil et al. [24] 2001 RCT 29 30 4 - 8 Bio-Oss®: 100%
Collagen
membrane: 15 29 Fixed 
prostheses
22.4
(12 - 40)
93
NR Mucosal tears: 5
No membrane coverage: 15 32 78
Wallace et al. 
[25] 2005 CCT 51
21
NR
Bio-Oss®: 100%;
PABG: 20% and 
Bio-Oss®: 80%
e-PTFE: 21 46
NR 12
98 17 51 32
NR37 Collagenmembrane: 37 83 98 18 56 26
6 No membrane coverage: 6 6 100 12 64 24
Choi et al. [26] 2009
RCT, 
split-
mouth
6 12 NR Bio-Oss®: 100%
Collagen membrane: 6
NR NR 8(7 - 9) NR
13a 36b 50c None
No membrane coverage: 6 12 55 33 Dehiscence: 1;swelling: 1
Barone et al. [27] 2013 RCT 18 18 < 5 PABG: 50%;MP3®: 50%
Collagen membrane: 9
NR NR 6 NR
31
(SD 16)
51
(SD 19)
18
(SD 20)
SMP: 1;
dehiscence: 1;
haematoma: 2
No membrane coverage: 9 28(SD 19)
59
(SD 15)
13
(SD 12)
SMP: 2;
dehiscence: 1;
haematoma: 2
García-Denche
et al. [28] 2013
RCT, 
split-
mouth
109
66
4 - 7 Bio-Oss®: 100%
Collagen membrane: 66
278
Fixed 
prostheses or 
bar retention
12
96.1d 19(SD 6)e
31
(SD 3)f
49
(SD 10)g None
69 No membrane coverage: 69 94.2 15(SD 5)
32
(SD 6)
56
(SD 21)
Displacement of 
grafting material: 4
aP = 0.937 (nonparametric Mann-Whitney U test); bP = 0.026 (nonparametric Mann-Whitney U test); cP = 0.093 (nonparametric Mann-Whitney U test); dP = 0.08 (Cohen´s f2 test); eP = 0.52 (non-parametric 
Wilcoxon t-test); fP = 1 (non-parametric Wilcoxon t-test); gP = 0.6 (non-parametric Wilcoxon t-test).
CCT = controlled clinical trial; e-PTFE = expanded polytetrafluoroethylene; LOP = length of observation period; MSFA = maxillary sinus floor augmentation; NFB = newly formed bone; NMT = non-
mineralised tissue; NOP = number of patients; PABG = particulated autogenous bone graft; PIMBL = peri-implant marginal bone loss; RCT = randomised controlled trial; RG = residual graft; SMP = sinus 
membrane perforation; SD = standard deviation.
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Corresponding measurements for no barrier 
membrane coverage was 12%, 64% and 24%. No 
statistical analysis was performed, but a higher 
percentage of newly formed bone and diminished 
percentage of non-mineralised tissue was observed 
after MSFA with barrier membrane coverage of the 
lateral window [25].
Percentage of newly formed bone, non-mineralised 
tissue and residual graft material after MSFA with a 
resorbable covering collagen barrier membrane (Bio-
Gide®) was 13%, 36% and 50%, after eight months, 
respectively [26]. Corresponding measurements 
without a membrane was 12%, 55% and 33%. There 
were no statistically significant differences in the 
new bone formation (P = 0.937) and residual grafting 
material (P = 0.093) after MSFA with or without 
barrier membrane coverage of the lateral window. 
However, the average percentage of non-mineralised 
tissue was statistically significant higher without 
barrier membrane coverage (P = 0.026) compared 
with barrier membrane coverage of the lateral window 
[26].
Percentage of newly formed bone, non-mineralised 
tissue and residual graft material after MSFA with 
a resorbable covering collagen barrier membrane 
(Evolution) was 31 (16)%, 51 (19)% and 18 (20)%, 
after six months, respectively [27]. Corresponding 
measurements without a membrane was 28 (19)%, 
59 (15)% and 13 (12)%. There was no statistically 
significant difference in the histomorphometric 
outcome after MSFA with or without barrier 
membrane coverage of the lateral window (P = 0.82), 
but a decreased percentage of non-mineralised tissue 
was observed with barrier membrane coverage [27].
Percentage of newly formed bone, non-mineralised 
tissue and residual graft material after MSFA with a 
covering barrier membrane (Bio-Gide®) was 19 (6)%, 
31 (3)% and 49 (10)%, after six months, respectively 
[28]. Corresponding measurements without a 
membrane was 15 (5)%, 32 (6)% and 56 (21)%. There 
was no statistically significant difference in newly 
formed bone (P = 0.52), non-mineralised tissue (P = 1) 
or residual graft material (P = 0.6) [28].
Meta-analysis
Meta-analysis (with random effect) where conducted 
to combine data from multiple studies where similar 
effects were measured. However meta-analysis can 
only be conducted for continuous data if both the 
mean and standard deviation (SD) are available 
of the percentage of newly formed bone and non-
mineralised tissue. Thus only three studies [17,27,28] 
met the inclusion requirement for the meta-analysis 
and the remaining studies [16,24-26] were excluded 
from the meta-analysis. One of the included studies 
[17] did not measure the mean percentage of non-
mineralised tissue and thus two studies were included 
in the meta-analysis of non-mineralised tissue and 
three studies were included in the meta-analysis of 
newly formed bone. Random effect analysis and 
test for heterogeneity was inconclusive due to the 
limited number of studies included. No statistically 
significant difference in heterogeneity between the 
included studies was found for newly formed bone 
(I2 = 0%, P = 0.803) [17,27,28], and non-mineralised 
tissue (I2 = 49%, P = 0.14) [27,28]. Meta-analysis 
showed a mean difference of newly formed bone of 
6.4% (confidence interval [CI] = 0 to 12.9) (Figure 
2) and non-mineralised tissue of -1.1% (CI = -2.7 
to 0.5) (Figure 3) demonstrating no statistically 
significant differences in newly formed bone and non-
mineralised tissue after MSFA with or without barrier 
membrane coverage of the lateral window. However, 
MSFA with barrier membrane coverage of the lateral 
window seems to be associated with an overall higher 
percentage of newly formed bone and diminish non-
mineralised tissue compared with the use of no barrier 
membrane coverage.
Summary
Histomorphometric evaluation revealed no 
statistically significant differences in percentage of 
newly formed bone and non-mineralised tissue after 
MSFA with or without barrier membrane coverage of 
the lateral window. However, a higher percentage of 
Figure 2. Meta-analysis using a random effect model assessing newly formed bone.
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newly formed bone and diminished non-mineralised 
tissue was observed with barrier membrane coverage 
of the lateral window compared with no barrier 
membrane coverage.
Biologic and mechanical complications
Mucosal tears were observed in five patients 
after MSFA [24]. No information was provided 
about the mucosal tears were related to the use of 
barrier membrane coverage of the lateral window 
[24].
Biologic complications involving soft tissue wound 
dehiscence and unexplained postoperative swelling 
was described in two patients after MSFA without 
barrier membrane coverage of the lateral window 
[26]. The complications were solved with antibiotic 
treatment [26].
Sinus membrane perforation occurred in both groups 
and was successfully treated with a resorbable 
collagen membrane [27]. Mild haematoma and soft 
tissue wound  dehiscence also occurred in both 
groups. There was no difference in the frequency of 
biologic complications between the two treatment 
modalities [27]. 
Unexplained pain occurred in three patients that 
resolved after treatment with Clindamycin [28]. 
Partial loss of grafting material into the subcutaneous 
space of the maxillary ridge occurred in four patients 
after MSFA without barrier membrane coverage of the 
lateral window [28].
Summary
Biologic and mechanical complications after MSFA 
were not reported in all included studies, but when 
reported, they were generally infrequent and not 
severe. Perforation of the sinus membrane was the 
most frequent intraoperative complication, but this 
does not seem to influence the final implant treatment 
outcome. Frequency of mucosal tears and soft tissue 
wound dehiscence seem to be comparable between the 
two treatment modalities. However, displacement of 
the grafting material into the subcutaneous space was 
only reported after MSFA without barrier membrane 
coverage of the lateral window.
Quality assessment
The quality of the included studies is summarised in 
Table 3. The controlled trial was characterised by high 
risk of bias [25]. Two randomised controlled trials 
were characterised by low risk of bias [26,27], one 
with moderate risk of bias [28], and three with high 
risk of bias [16,17,24]. 
DISCUSSION
The objective of the present systematic review 
and meta-analysis was to test the hypothesis of 
no difference in implant treatment outcomes after 
MSFA with or without barrier membrane coverage of 
Figure 3. Meta-analysis using a random effect model assessing non-mineralised tissue.
 Table 3. Quality assessment of included studies
Study Random selectionin the population
Definition of inclusion
and exclusion criteria
Report of losses
to follow-up
Validated
measurements
Statistical
analysis
Risk of
bias
Froum et al. [16] Yes Yes No Yes No High
Tarnow et al. [17] Yes Yes No Yes No High 
Tawil et al. [24] Yes Yes No Yes No High
Wallace et al. [25] No Yes No Yes No High
Choi et al. [26] Yes Yes Yes Yes Yes Low
Barone et al. [27] Yes Yes Yes Yes Yes Low
García-Denche et al. [28] Yes Yes No Yes Yes Moderate
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the lateral window. The electronic search and hand-
searching resulted in 1068 entries. One controlled 
trial [25] with high risk of bias and six randomised 
controlled trials [16,17,24,26-28] characterised by 
low [26,27], moderate [28] and high risk of bias 
[16,17,24], fulfilled the inclusion criteria and were 
included in the final synthesis. 
The result of the present systematic review and meta-
analysis demonstrated no statistically significant 
difference in implant survival rate, newly formed 
bone or non-mineralised tissue after MSFA with or 
without barrier membrane coverage of the lateral 
window. However, barrier membrane coverage of the 
lateral window generally increases the percentage 
of newly formed bone and diminishes proliferation 
of non-mineralised tissue. Thus, MSFA with barrier 
membrane coverage of the lateral window seems 
to be beneficial and improve bone regeneration. 
However, considerable variations in study design, 
small patient samples and type of outcome measures 
as well as various methodological confounding factors 
posed serious restrictions to review the literature 
in a quantitative systematic manner. Hence, the 
conclusions drawn from the results of the present 
systematic review should be interpreted with extreme 
caution and well-designed randomised controlled 
trials with larger patient samples are needed before 
definite conclusions can be provided about the 
effectiveness of barrier membrane coverage of the 
lateral window in conjunction with MSFA.
The included studies of the present systematic review 
revealed a tendency towards higher percentage of 
newly formed bone and diminished non-mineralised 
tissue after MSFA with barrier membrane coverage 
of the lateral window compared with no barrier 
membrane coverage [16,17,25-28]. Moreover, soft 
tissue adherence to the graft particles and infiltration 
of connective tissue into the grafting material was 
reported after MSFA without barrier membrane 
coverage of the lateral window [26]. However, the 
histomorphometric outcome after MSFA with or 
without barrier membrane coverage are influences 
by numerous factors including the dimension of 
the lateral window, volume of the maxillary sinus 
cavity, type of grafting material and the residual 
alveolar bone height [34-36]. A statistically 
significant higher percentage of newly formed bone 
and diminished non-mineralised tissue have been 
reported after MSFA with reduced dimension of 
the lateral window compared with larger dimension 
[34]. In the present systematic review, the dimension 
of the lateral window was measured in one of the 
included studies demonstrating higher percentage 
of newly formed bone and diminishes non-
mineralised tissue with barrier membrane coverage 
compared with no membrane coverage, when the 
dimension of the lateral window was equivalent 
[27]. Consequently, the histomorphometric outcome 
is improved after MSFA with barrier membrane 
coverage when the dimension of the lateral window 
is equivalent. 
Recent studies have demonstrated that the percentage 
of newly formed bone is inversely proportional to 
the bucco-palatal distance of the maxillary sinus. 
Thus, the volume of the maxillary sinus cavity also 
influences the amount of bone regeneration [36-39]. 
However, none of the included studies of the present 
systematic review evaluated the dimension of the 
maxillary sinus cavity or standardised the quantity of 
the grafting material. 
A recent systematic review and meta-analysis 
assessing histomorphometric variables after MSFA 
concluded that autogenous bone graft revealed the 
highest amount of newly formed bone compared with 
other grafting materials [35]. The included studies 
of the present systematic review used dissimilar 
grafting materials and the histomorphometric outcome 
are thus not factual comparable. Consequently, 
histomorphometric outcome after MSFA is influenced 
by several confounding factors, which is not taken 
into account in the present systematic review.
A newly published retrospective study concluded 
that MSFA with barrier membrane coverage of 
the lateral window diminishes postoperative 
displacement of the grafting material and prevents 
bone substitutes particles from penetrating within 
the buccal mucosa [40]. One of the included 
studies of the present systematic review reported 
displacement of the grafting material into the 
subcutaneous space after MSFA without barrier 
membrane coverage [28]. Haemorrhage and swelling 
of the Schneiderian membrane after MSFA combined 
with the physiologically positive air pressure of 
the maxillary sinus may cause displacement of the 
grafting material through the lateral window, if the 
lateral window is left uncovered [28,40]. Thus, it 
is important that patients are instructed not to blow 
their nose and sneeze with open mouth after MSFA 
without barrier membrane coverage of the lateral 
window.
Changes in Schneiderian membrane thickness after 
MSFA have previously been assessed by cone beam 
computed tomography demonstrating a transient 
swelling of the Schneiderian membrane, which 
reaches the highest value one week after surgery and 
completely resolves over months [41,42]. The use of 
a larger graft volume was positively correlated with 
an increase in postoperative Schneiderian membrane 
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thickness [41]. Moreover, a recent computed 
tomographic study demonstrated that displacement of 
the grafting material was also influenced by the used 
volume of the grafting material [40]. Consequently, 
MSFA without barrier membrane coverage of the 
lateral window is associated with an increased risk 
of postoperatively displacement of the grafting 
material due to transient swelling of the Schneiderian 
membrane, size of the lateral window and volume 
of the grafting material. Thus, membrane coverage 
of the lateral window seems to stabilise and prevent 
displacement of the grafting material.  
Systematic reviews provide a meticulous summary of 
the current evidence related to a research question or 
hypothesis. Meta-analysis is the statistical synthesis 
of the results included in the systematic review. 
The strength of evidence from a systematic review 
and meta-analysis is therefore related to the quality 
of the included studies. High quality randomised 
controlled trials with low risk of bias provide the 
highest level of evidence for ascertaining the safety 
and efficacy of a specific surgical intervention. The 
histomorphometric outcome of the present systematic 
review and meta-analysis is based on one randomised 
controlled trials with low risk of bias [27], one 
with moderate risk of bias [28], and one with high 
risk of bias [17]. Consequently, the current level 
of evidence is inadequate to propose implications 
for evidence based clinical guidelines according 
to the focus question of the present systematic 
review. 
CONCLUSIONS
The present systematic review and meta-analysis 
revealed no statistically significant difference 
in implant treatment outcomes after maxillary 
sinus floor augmentation with or without barrier 
membrane coverage of the lateral window. However, 
barrier membrane coverage increases percentage of 
newly formed bone, diminish proliferation of non-
mineralised tissue and prevent displacement of the 
grafting material. Thus, barrier membrane coverage of 
the lateral window seems to be beneficial and improve 
implant treatment outcomes. However, small patient 
samples, dissimilar evaluation methods, different 
outcome measures and various methodological 
confounding factors posed serious restrictions 
reviewing the literature in a quantitative systematic 
manner. Hence, the conclusions drawn from the 
results of the present systematic review should be 
interpreted with extreme caution and well-designed 
randomised controlled trials that follow Consolidated 
Standards of Reporting Trials (CONSORT) guidelines 
are needed before definite conclusions can be 
provided about the effectiveness of barrier membrane 
coverage of the lateral window. 
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Appendix 1. PRISMA checklist [22]
Section/topic # Checklist item Reported on page #
TITLE
Title 1 Identify the report as a systematic review, meta-analysis, or both. 1
ABSTRACT
Structured summary 2
Provide a structured summary including, as applicable: background; objectives; data sources; study 
eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; 
limitations; conclusions and implications of key findings; systematic review registration number. 
2
INTRODUCTION
Rationale 3 Describe the rationale for the review in the context of what is already known. 4
Objectives 4 Provide an explicit statement of questions being addressed with reference to participants, interven-tions, comparisons, outcomes, and study design (PICOS). 4,5
METHODS
Protocol and registra-
tion 5
Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if 
available, provide registration information including registration number. 6
Eligibility criteria 6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale. 6,7,9
Information sources 7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched. 7,8
Search 8 Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated. 8
Study selection 9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis). 8,9
Data collection 
process 10
Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) 
and any processes for obtaining and confirming data from investigators. 9,10
Data items 11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made. 10
Risk of bias in indi-
vidual studies 12
Describe methods used for assessing risk of bias of individual studies (including specification of 
whether this was done at the study or outcome level), and how this information is to be used in any 
data synthesis. 
10,11
Summary measures 13 State the principal summary measures (e.g., risk ratio, difference in means). Not reported
Synthesis of results 14 Describe the methods of handling data and combining results of studies, if done, including mea-sures of consistency (e.g., I2) for each meta-analysis. 12,13
Risk of bias across 
studies 15
Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication 
bias, selective reporting within studies). Not reported
Additional analyses 16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified. Not reported
RESULTS
Study selection 17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram. 13
Study characteristics 18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations. 13-15
Risk of bias within 
studies 19
Present data on risk of bias of each study and, if available, any outcome level assessment (see item 
12). 21
Results of individual 
studies 20
For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data 
for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot. 15-21
Synthesis of results 21 Present results of each meta-analysis done, including confidence intervals and measures of con-sistency. 18,19
Risk of bias across 
studies 22 Present results of any assessment of risk of bias across studies (see Item 15). 21
Additional analysis 23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 16]). Not reported
DISCUSSION
Summary of evidence 24 Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers). 21
Limitations 25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incom-plete retrieval of identified research, reporting bias). 21,22
Conclusions 26 Provide a general interpretation of the results in the context of other evidence, and implications for future research. 24,25
FUNDING
Funding 27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review. 25
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Appendix 2. PubMed search until the 5th of July, 2019
Search Add to builder Query
Items 
found
#48 Add
Search ((((Osteotomy[tw] OR lateral[tw] OR window[tw])) AND ((((“Sinus Floor Augmentation”[Mesh]) OR 
(((((“Maxillary Sinus”[Mesh]) OR Maxillary Sinus[Text Word]) OR sinus floor[Text Word])) AND ((“Bone 
Transplantation”[Mesh]) OR ((transplant*[Text Word] OR augmentat*[Text Word] OR elevat*[Text Word] OR 
graft*[Text Word] OR lift*[Text Word])))))) AND membrane*[Text Word])))
469
Appendix 3. Embase search until the 5th of July, 2019
No. Query Results
#15 #10 AND #13 AND #14 442
#14 osteotomy:ti,ab,kw,de OR lateral:ti,ab,kw,de OR window*:ti,ab,kw,de 512091
#13 #11 OR #12 1381887
#12 ‘artificial membrane’/exp 47221
#11 membrane*:ti,ab,kw,de 1380557
#10 #1 OR #9 3339
#9 #5 AND #8 3339
#8 #6 OR #7 1939869
#7 transplant*:ti,ab,kw OR augmentat*:ti,ab,kw OR graft*:ti,ab,kw OR elevat*:ti,ab,kw OR lift*:ti,ab,kw 1920983
#6 ‘bone transplantation’/exp 51406
#5 #2 OR #3 OR #4 17891
#4 (sinus NEAR/2 floor):ti,ab,kw,de 2001
#3 ((maxilla* OR maxillar*) NEAR/2 sinus):ti,ab,kw,de 17442
#2 ‘maxillary sinus’/exp 12055
#1 ‘sinus floor augmentation’/exp 991
Appendix 4. Cochrane Library search until the 5th of July, 2019
ID Search Hits
#1 MeSH descriptor: [Sinus Floor Augmentation] explode all trees 134
#2 ((maxiilla* OR maxillary) NEAR/2 Sinus) 613
#3 sinus NEAR/2 floor 338
#4 #2 OR #3 712
#5 MeSH descriptor: [Bone Transplantation] explode all trees 886
#6 transplant* OR augmentat* OR graft* OR elevat* OR lift* 108626
#7 #5 OR #6 108626
#8 #4 AND #7 456
#9 #1 OR #8 456
#10 MeSH descriptor: [Membranes, Artificial] explode all trees 1174
#11 membrane* 16574
#12 #10 OR #11 16908
#13 osteotomy OR lateral OR window* 20494
#14 #9 AND #13 AND #13 156
